KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes... << Prices as on Jan 09, 2026 >>  ABB India 5092.7  [ 1.02% ]  ACC 1703.5  [ -1.23% ]  Ambuja Cements 536.95  [ -1.83% ]  Asian Paints Ltd. 2824.5  [ 1.36% ]  Axis Bank Ltd. 1271.95  [ -1.16% ]  Bajaj Auto 9557.4  [ -2.08% ]  Bank of Baroda 300.45  [ 0.23% ]  Bharti Airtel 2027.3  [ -1.89% ]  Bharat Heavy Ele 274.7  [ 0.88% ]  Bharat Petroleum 354.3  [ -0.08% ]  Britannia Ind. 5977.65  [ -0.91% ]  Cipla 1466.15  [ 0.38% ]  Coal India 418.45  [ -1.58% ]  Colgate Palm 2056.7  [ 0.54% ]  Dabur India 522.2  [ 0.56% ]  DLF Ltd. 671.3  [ -3.03% ]  Dr. Reddy's Labs 1209.45  [ 0.16% ]  GAIL (India) 164.4  [ 0.58% ]  Grasim Inds. 2775.55  [ -0.57% ]  HCL Technologies 1662.3  [ 0.86% ]  HDFC Bank 938.7  [ -0.83% ]  Hero MotoCorp 5773.45  [ -1.36% ]  Hindustan Unilever 2373.75  [ -0.53% ]  Hindalco Indus. 901.55  [ -0.21% ]  ICICI Bank 1403.55  [ -2.22% ]  Indian Hotels Co 693.25  [ -1.51% ]  IndusInd Bank 882.1  [ -0.11% ]  Infosys L 1614.75  [ 0.10% ]  ITC Ltd. 337.1  [ -1.11% ]  Jindal Steel 1010.5  [ -0.37% ]  Kotak Mahindra Bank 2126.75  [ -0.29% ]  L&T 4026.75  [ -0.03% ]  Lupin Ltd. 2181.45  [ -0.41% ]  Mahi. & Mahi 3677.05  [ -1.26% ]  Maruti Suzuki India 16501  [ -0.98% ]  MTNL 34.39  [ -1.40% ]  Nestle India 1298.95  [ -0.59% ]  NIIT Ltd. 85.38  [ -3.63% ]  NMDC Ltd. 80.55  [ -1.31% ]  NTPC 336.05  [ -2.34% ]  ONGC 234.1  [ 1.14% ]  Punj. NationlBak 122.85  [ 0.04% ]  Power Grid Corpo 258.55  [ -0.37% ]  Reliance Inds. 1475.3  [ 0.34% ]  SBI 1000  [ 0.22% ]  Vedanta 609.9  [ 1.05% ]  Shipping Corpn. 214.65  [ -1.51% ]  Sun Pharma. 1729.95  [ -1.79% ]  Tata Chemicals 747.25  [ -2.16% ]  Tata Consumer Produc 1175.5  [ -1.85% ]  Tata Motors Passenge 354.3  [ -1.42% ]  Tata Steel 178.3  [ -1.05% ]  Tata Power Co. 364.85  [ -2.50% ]  Tata Consultancy 3208  [ 0.12% ]  Tech Mahindra 1581.2  [ 0.23% ]  UltraTech Cement 11951.85  [ -0.89% ]  United Spirits 1329.8  [ -1.42% ]  Wipro 261.9  [ -0.13% ]  Zee Entertainment En 91.04  [ 0.52% ]  

Company Information

Indian Indices

  • Loading....

Global Indices

  • Loading....

Forex

  • Loading....

PANACEA BIOTEC LTD.

09 January 2026 | 12:00

Industry >> Pharmaceuticals

Select Another Company

ISIN No INE922B01023 BSE Code / NSE Code 531349 / PANACEABIO Book Value (Rs.) 134.92 Face Value 1.00
Bookclosure 27/09/2024 52Week High 582 EPS 0.00 P/E 0.00
Market Cap. 2488.01 Cr. 52Week Low 281 P/BV / Div Yield (%) 3.01 / 0.00 Market Lot 1.00
Security Type Other

ACCOUNTING POLICY

You can view the entire text of Accounting Policy of the company for the latest year.
Year End :2025-03 

Summary of Material Accounting Policies

1. Company information

Panacea Biotec Limited (Corporate identification number: L33117PB1984PLC022350) ('PBL' or the 'Company') is a public company
incorporated and domiciled in India. The Company has its registered office at Ambala-Chandigarh Highway, Lalru-140501, Punjab,
India. The Company has been incorporated under the provisions of Indian Companies Act, 1956 and is existing under the provisions
of Indian Companies Act, 2013. Equity shares are listed with BSE Limited and National Stock Exchange of India Limited.

Company overview

The Company is one of India's leading research-based biotechnology companies engaged in the business of research, development,
manufacture and marketing of vaccines in India and international markets. The Company's wholly owned subsidiary company
viz. Panacea Biotec Pharma Ltd. is engaged in the business of research, development, manufacture and marketing of branded
pharmaceutical formulations and nutritional products in India and international markets.

1.1 Basis of preparation

a. Statement of compliance

The standalone financial statements have been prepared in accordance with Indian Accounting Standards ("Ind AS") as
notified by Ministry of Corporate Affairs pursuant to Section 133 of the Companies Act, 2013 (the "Act") read with Rule 3 of the
Companies (Indian Accounting Standards) Rules, 2015 and under relevant provisions of the Act as amended from time to time.
These standalone financial statements have been prepared for the Company on the going concern basis in accordance with
accounting principles generally accepted in India and on the basis of relevent Ind AS that are effective on a reporting date i.e.
March 31,2025. These standalone financial statements were approved by the board of Directors of the Company on May 30,
2025.

b. Basis of measurement

The standalone financial statements have been prepared on a historical cost basis, except for the following assets and liabilities
which have been measured at fair value:

• Certain financial assets and liabilities measured at fair value (refer accounting policy regarding financial instruments); and

• Defined benefit plans - plan assets measured at fair value.

1.2 Use of estimates and judgements

The preparation of the standalone financial statements in conformity with Ind AS requires management to make estimates,
judgments and assumptions. These estimates, judgments and assumptions affect the application of accounting policies and the
reported amounts of assets and liabilities, the disclosures of contingent assets and liabilities at the date of the financial statements
and reported amounts of revenues and expenses during the period. Accounting estimates could change from period to period.
Actual results could differ from those estimates. Appropriate changes in estimates are made as management becomes aware of
changes in circumstances surrounding the estimates. Changes in estimates are reflected in the financial statements in the period
in which changes are made and, if material, their effects are disclosed in the notes to the standalone financial statements.

Application of accounting policies that require critical accounting estimates involving complex and subjective judgments and the
use of assumptions in these standalone financial statements have been disclosed in note 1.4.

1.3 Material accounting policies

The material accounting policies that are used in the preparation of these financial statements are summarised below. These
accounting policies are consistently used throughout the periods presented in the standalone financial statements.

a. Current versus non-current classification

The Company has considered an operating cycle of 12 months for determining current and non-current classification of
assets and liabilities in the balance sheet. Deferred tax assets and liabilities are classified as non-current assets and liabilities
respectively.

b. Inventories

Inventories are valued as follows:

Raw material, components, stores and spares: Raw materials (including packing materials), stores and spares are valued at
lower of cost or net realisable value. However, materials and other items held for use in the production of inventories are not
written down below cost if the finished products in which they will be incorporated are expected to be sold at or above cost.
Cost of raw materials, components and stores and spares is determined on a weighted average basis. Stores and spares having
useful life of more than twelve months are capitalised as "Property, plant and equipment" and are depreciated prospectively
over their remaining useful lives in accordance with Ind AS 16.

Work in progress and finished goods : Work in progress and finished goods are valued at lower of cost or net realisable value.
Cost includes raw material cost and a proportion of direct and indirect overheads up to estimated stage of completion. Cost is
determined on a weighted average basis.

Traded goods : Traded goods are valued at lower of cost or net realisable value. Cost includes cost of purchase and other cost
incurred in bringing the inventories to their present location and condition. Cost is determined on weighted average basis.

Provision for expired / slow-moving / non-moving inventories: The provision for inventories are created as follows:

Following are the exceptions:

i. Provision in respect of any inventory item that is the subject matter of any legal dispute shall be created based on the
legal opinion from the legal department.

ii. All exceptions will have to be approved by the Chief Financial Officer of the Company.

iii. In case of inventory items on which provisions were made as per the policy however such items were subsequently
consumed / utilised, then the provision made in respect of such an inventory shall be adjusted suitably.

Net realisable value is the estimated selling price in the ordinary course of business, less estimated costs of completion
and estimated costs necessary to make the sale.

c. Property, plant and equipment

Recognition and initial measurement : All items of property, plant and equipment are initially measured at cost. The cost
comprises purchase price, borrowing cost if capitalisation criteria are met and directly attributable cost of bringing the
asset to its working condition for the intended use. Any trade discount and rebates are deducted in arriving at the purchase
price. Subsequent to initial recognition, property, plant and equipment other than freehold land are measured at cost less
accumulated depreciation and accumulated impairment losses. Subsequent costs are included in the asset's carrying amount
or recognised as a separate asset, as appropriate, only when it is probable that future economic benefits attributable to such
subsequent cost associated with the item will flow to the Company. All other repair and maintenance costs are recognised in
statement of profit and loss as incurred.

The cost of replacing part of an item of property, plant and equipment is recognised in the carrying amount of the item if it is
probable that the future economic benefits embodied within the part will flow to the Company and its cost can be measured
reliably. The costs of repairs and maintenance are recognised in the statement of profit and loss as incurred.

Advances paid towards the acquisition of property, plant and equipment outstanding at each reporting date is disclosed as
capital advances under non-current assets.

Capital work-in-progress included in property, plant and equipment are not depreciated as these assets are not yet available
for use.

i) Freehold land has an unlimited useful life and therefore is not depreciated.

ii) Leasehold land is amortised over the period of lease.

iii) Leasehold improvements are amortised over the initial period of lease or useful life, whichever is shorter.

The residual values, useful lives and method of depreciation are reviewed at each financial year end and adjusted prospectively,
if appropriate.

Where, during any financial year, any addition has been made to any asset, or where any asset has been sold, discarded,
demolished or destroyed, or significant components replaced; depreciation on such assets is calculated on a pro rata basis as
individual assets with specific useful life from the month of such addition or, as the case may be, up to the month on which
such asset has been sold, discarded, demolished or destroyed or replaced.

De-recognition : An item of property, plant and equipment and any significant part initially recognised is de-recognised upon
disposal or when no future economic benefits are expected from its use or disposal. Any gain or loss arising on de-recognition
of the asset (calculated as the difference between the net disposal proceeds and the carrying amount of the asset) is included
in the statement of profit and loss when the asset is derecognized.

d. Intangible assets

Recognition and initial measurement

Research and development costs : Expenditure on the research phase of projects is recognised as an expense as incurred. Costs
that are directly attributable to a project's development phase are recognised as intangible assets, provided the Company can
demonstrate the following:

• the technical feasibility of completing the intangible asset so that it will be available for use.

• the management's intention is to complete the intangible asset and use or sell it

• its ability to use or sell the intangible asset

• how the intangible asset will generate probable future economic benefits

• the availability of adequate technical, financial and other resources to complete the development and to use or sell the
intangible asset.

• its ability to measure reliably the expenditure attributable to the intangible asset during its development
Development costs not meeting these criteria for capitalisation are expensed as and when incurred.

Directly attributable costs include employee costs incurred on development of prototypes along with an appropriate portion
of relevant overheads and borrowing costs.

Other intangibles : Intangible assets acquired separately are measured on initial recognition at cost. Following initial
recognition, intangible assets are carried at cost less accumulated amortisation and accumulated impairment losses, if any.
Internally generated intangible assets, excluding product development costs, are not capitalised and expenditure is reflected
in the statement of profit and loss in the year in which the expenditure is incurred.

Intangible assets under development are not amortized as these assets are not yet available for use. These assets are evaluated
for potential impairment on an annual basis or when there are indications that the carrying value is not recoverable.
Subsequent measurement (Amortisation and useful lives) : All finite-lived intangible assets, including internally developed
intangible assets, are accounted for using the cost model whereby capitalised costs are amortised on a straight-line basis over
their estimated useful lives. Residual values and useful lives are reviewed at each reporting date and any change in the same
is accounted for prospectively. The following useful lives are applied:

The amortization expense on intangible assets with finite life is recognised in the statement of profit and loss under the head
depreciation and amortization expense.

De-recognition : Gains or losses arising from de-recognition of an intangible asset are measured as the difference between the
net disposal proceeds and the carrying amount of the asset and are recognised in the statement of profit and loss when the
asset is derecognised.

e. Investment properties

Recognition and initial measurement : Investment properties are properties held to earn long term rentals or for capital
appreciation, or both. Investment properties are measured initially at their cost of acquisition, including transaction costs.
Subsequent costs are included in the asset's carrying amount or recognized as a separate asset, as appropriate, only when it is
probable that future economic benefits associated with the asset will flow to the Company. All other repair and maintenance
costs are recognised in statement of profit and loss as incurred.

Properties held under leases are classified as investment properties when it is held to earn rentals or for capital appreciation
or for both, rather than for sale in the ordinary course of business or for use in production or administrative functions.

Subsequent measurement (depreciation and useful lives) : Investment properties are subsequently measured at cost less
accumulated depreciation and accumulated impairment losses, if any. Depreciation on investment properties is provided on the
straight-line method over the lease period of the right-of-use assets.

Though, the Company measures investment properties using cost-based measurement, the fair value of investment property is
disclosed in the notes. Fair values are determined based on an annual evaluation performed by an accredited external independent
valuer applying a valuation model acceptable internationally.

De-recognition : Investment properties are de-recognized either when they have been disposed of or when they are
permanently withdrawn from use and no future economic benefit is expected from their disposal. The difference between
the net disposal proceeds, if any, and the carrying amount of the asset is recognised in the statement of profit and loss in the
period of de-recognition.

f. Impairment of non-financial assets / Assets classified as held for sale

The carrying amounts of the Company's non-financial assets, other than inventories and deferred tax assets are reviewed at
each reporting date to determine whether there is any indication of impairment. If any such indication exists, then the asset's
recoverable amount is estimated. Goodwill and intangible assets that have indefinite lives or that are not yet available for use
are tested for impairment annually; their recoverable amount is estimated annually each year at the reporting date.

For the purpose of impairment testing, assets are grouped together into the smallest group of assets that generates cash
inflows from continuing use that are largely independent of the cash inflows of other assets or groups of assets (the 'cash¬
generating unit'). The recoverable amount of an asset or cash-generating unit is the greater of its value in use or its fair value
less costs to sell. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre¬
tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset. The
goodwill acquired in a business combination is, for the purpose of impairment testing, allocated to cash-generating units
that are expected to benefit from the synergies of the combination. Intangibles with indefinite useful lives are tested for
impairment individually.

An impairment loss is recognised if the carrying amount of an asset or its cash-generating unit exceeds its estimated recoverable
amount. Impairment losses recognised in respect of cash-generating units are allocated first to reduce the carrying amount of
any goodwill allocated to the units and then to reduce the carrying amount of the other assets in the unit on a pro-rata basis.
Impairment losses are recognised in the statement of profit and loss.

Impairment losses recognised in prior periods are assessed at each reporting date for any indications that the loss has
decreased or no longer exists. An impairment loss is reversed if there has been a change in the estimates used to determine
the recoverable amount. An impairment loss is reversed only to the extent that the asset's carrying amount does not exceed
the carrying amount that would have been determined, net of depreciation or amortisation, if no impairment loss had been
recognised.

During the current financial year, the Company has considered it appropriate to undertake the impairment assessment based
on certain indicators. With reference to the latest business plan, the decline in operating profits is considered temporary.

Based on management's impairment assessment, recoverable amount is higher than the carrying amount of property, plant
and equipment and hence, no impairment is recognized.

g. Borrowing costs

Borrowing costs directly attributable to the acquisition, construction or production of an asset that necessarily takes a
substantial period of time to get ready for its intended use or sale are capitalised as part of the cost of the asset. All other
borrowing costs are expensed in the period in which they occur. Borrowing cost consists of interest, ancillary costs and other
costs in connection with the borrowing and also includes exchange differences to the extent regarded as an adjustment to
the borrowing costs.

h. Foreign and presentation currency

The financial statements are presented in Indian Rupees (?), which is also the Company's functional and presentation currency.

Rounding of amount : All amounts disclosed in the financial statements and notes have been rounded-off to the nearest
? million or decimal thereof as per the requirement of Schedule III, unless otherwise stated. Amount less than ?50,000 is
presented ?0.00 million.

Foreign currencies transactions and balances

Initial recognition : Transactions in foreign currencies are initially recorded by the Company at its functional currency spot
rates at the date the transaction first qualifies for recognition.

Subsequent measurement : Monetary assets and liabilities denominated in foreign currencies are translated at the functional
currency spot rates of exchange at the reporting date.

Exchange differences arising on settlement or translation of monetary items are recognised in the statement of profit and loss
in the year in which they arise.

Non-monetary items that are measured in terms of historical cost in a foreign currency are translated using the exchange
rates at the dates of the initial transactions. Non-monetary items measured at fair value in a foreign currency are translated
using the exchange rates at the date when the fair value is determined. The gain or loss arising on translation of non-monetary
items measured at fair value is treated in line with the recognition of the gain or loss on the change in fair value of the item (i.e.
translation differences on items whose fair value gain or loss is recognised in Other Comprehensive Income ("OCI") or profit or
loss are also recognised in OCI or profit or loss, respectively).

Exchange differences arising on other long-term foreign currency monetary items are accumulated in the "Foreign Currency
Monetary Item Translation Difference Account" and amortised over the remaining life of the concerned monetary item.

All other exchange differences are charged to the statement of profit and loss.

i. Fair value measurement

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between
market participants at the measurement date. The fair value measurement is based on the presumption that the transaction
to sell the asset or transfer the liability takes place either:

• In the principal market for the asset or liability, or

• In the absence of a principal market, in the most advantageous market for the asset or liability
The principal or the most advantageous market must be accessible by the Company.

The fair value of an asset or a liability is measured using the assumptions that market participants would use when pricing the
asset or liability, assuming that market participants act in their economic best interest.

A fair value measurement of a non-financial asset takes into account a market participant's ability to generate economic
benefits by using the asset in its highest and best use or by selling it to another market participant that would use the asset in
its highest and best use.

Company uses valuation techniques that are appropriate in the circumstances and for which sufficient data are available to
measure fair value, maximizing the use of relevant observable inputs and minimizing the use of unobservable inputs.

All assets and liabilities for which fair value is measured or disclosed in the financial results are categorized within the fair value
hierarchy, described as follows, based on the lowest level input that is significant to the fair value measurement as a whole:
Level 1 — Quoted (unadjusted) market prices in active markets for identical assets or liabilities

Level 2 — Valuation techniques for which the lowest level input that is significant to the fair value measurement is directly or
indirectly observable

Level 3 — Valuation techniques for which the lowest level input that is significant to the fair value measurement is unobservable
For assets and liabilities that are recognized in the financial statements on a recurring basis, Company determines whether
transfers have occurred between levels in the hierarchy by re-assessing categorization (based on the lowest level input that is
significant to the fair value measurement as a whole) at the end of each reporting period or each case.

j. Revenue recognition

Revenue is measured based on the consideration specified in a contract with a customer and excludes amounts collected
on behalf of third parties, if any. The Company recognises revenue when it transfers control over a product or service to a
customer.

The Company has concluded that it is the principal in all of its revenue arrangements since it is the primary obligor in all the
revenue arrangements as it has pricing latitude and is also exposed to inventory and credit risks.

The Company applies the revenue recognition criteria to each separately identifiable component of the Revenue transaction
as set out below:

Sale of goods : Revenue from sale of goods is recognised when all the significant risks and rewards of ownership in the goods
are transferred to the buyer as per the terms of the contract, there is neither continuing managerial involvement with the goods
nor effective control over the goods sold, it is probable that economic benefits will flow to the Company, the costs incurred or to
be incurred in respect of the transaction can be measured reliably and the amount of revenue can be measured reliably.

Revenue towards satisfaction of a performance obligation is measured at the amount of transaction price allocated to that
performance obligation. The transaction price of goods sold is net of variable consideration on account of discounts. Revenue
is disclosed exclusive of goods and services tax.

Revenue from these sales is recognised based on the price specified in the contract, net of the estimated volume discounts.
Accumulated experience is used to estimate and provide for the discounts, using the expected value method, and revenue is
only recognised to the extent that it is highly probable that a significant reversal will not occur.

The Company enters into arrangements for the sale of its products in certain markets. Under such arrangements, the Company
sells its products at an agreed price mentioned in the arrangement and is also entitled to a profit share which is over and above
the agreed price. The profit share is dependent on the ultimate net sale proceeds or net profits, subject to any reductions or
adjustments that are required by the terms of the arrangement. Revenue in an amount equal to the base supply price is
recognised in these transactions upon delivery of products to the business partners. An additional amount representing the profit
share component is recognised as revenue only to the extent that it is highly probable that a significant reversal will not occur.

Revenue from services rendered is recognised in the statement of profit and loss over the period the underlying services are
performed.

Dividend income : Dividend income is recognised at the time when right to receive the payment is established, which is
generally when the shareholders approve the dividend.

Interest income : Interest income is recorded on accrual basis using the effective interest rate ("EIR") method.

Royalty income : Royalty is recognized on an accrual basis based on actual sale of product by the licensee and in accordance
with the terms of the relevant agreement.

Research and license fees income : Research and license fees income is recognized on an accrual basis based on actual sale of
product by the licensee and in accordance with the term of the relevant agreement.

Export incentives : Export entitlements from government authorities are recognised in the statement of profit and loss when
the right to receive credit as per the terms of the scheme is established in respect of the exports made by the Company, and
where there is no significant uncertainty regarding the ultimate collection of the relevant export proceeds.

A provisions for expected sales returns is determined based on the historical percentage of sales return for the same types
of goods for which the provision is currently being determined. The same percentage to the sales is applied for the current
accounting period to derive the provision for sales return to be accrued. It is very unlikely that actual sales return will exactly
match the historical percentage. These estimates are reviewed annually for any material changes in assumptions and likelihood
of occurrence.

k. Financial instruments

Financial instruments are recognised when the Company becomes a party to the contractual provisions of the instrument and
are measured initially at fair value adjusted for transaction costs, except for those carried at fair value through profit or loss
which are measured initially at fair value. However, trade receivables that do not contain a significant financing component
are measured at transaction price.

Recognition and initial measurement : Financial assets and financial liabilities are recognised when the Company becomes
a party to the contractual provisions of the instrument and are measured initially at fair value adjusted for transaction costs,
except for those carried at fair value through profit or loss which are measured initially at fair value.

Subsequent measurement
Financial assets

i. Financial assets carried at amortised cost - A financial instrument is measured at amortised cost if both the following
conditions are met:

• The asset is held within a business model whose objective is to hold assets for collecting contractual cash flows, and

• Contractual terms of the asset give rise on specified dates to cash flows that are solely payments of principal and
interest ("SPPI") on the principal amount outstanding.

After initial measurement, such financial assets are subsequently measured at amortised cost using the effective interest
method.

ii. Investments in equity instruments of subsidiaries and joint ventures - Investments in equity instruments of subsidiaries
and joint ventures are accounted for at cost in accordance with Ind AS 27 Separate Financial Statements.

iii. Financial assets at fair value

Investments in equity instruments other than above - Investments in equity instruments which are held for trading are
generally classified as at fair value through profit or loss ("FVTPL"). For all other equity instruments, the Company makes
irrevocable choice upon initial recognition, on an instrument to instrument basis, to classify the same either as at fair value
through other comprehensive income ("FVOCI") or fair value through profit or loss FVTPL.

If the Company decides to classify an equity instrument as at FVOCI, then all fair value changes on the instrument,
excluding dividends, are recognised in the OCI. There is no recycling of the amounts from OCI to profit or loss, even on sale
of investment. However, the Company transfers the cumulative gain or loss within equity. Dividends on such investments
are recognised in the statement of profit and loss unless the dividend clearly represents a recovery of part of the cost of
the investment.

Equity instruments included within the FVTPL category are measured at fair value with all changes recognised in the profit
or loss.

De-recognition of financial assets : A financial asset is primarily de-recognised when the rights to receive cash flows from the
asset have expired or the Company has transferred its rights to receive cash flows from the asset.

Financial liabilities

Subsequent to initial recognition, all non-derivative financial liabilities, other than derivative liabilities, are subsequently
measured at amortised cost using the effective interest method.

De-recognition of financial liabilities : A financial liability is de-recognised when the obligation under the liability is discharged
or cancelled or expires. When an existing financial liability is replaced by another from the same lender on substantially
different terms, or the terms of an existing liability are substantially modified, such an exchange or modification is treated
as the de-recognition of the original liability and the recognition of a new liability. The difference in the respective carrying
amounts is recognised in the statement of profit and loss.

Offsetting of financial instruments : Financial assets and financial liabilities are offset and the net amount is reported in the
balance sheet if there is a currently enforceable legal right to offset the recognised amounts and there is an intention to settle
on a net basis, to realize the assets and settle the liabilities simultaneously.

Impairment of financial assets : The Company assesses on a forward looking basis the expected credit losses associated with
its assets carried at amortised cost. The impairment methodology applied depends on whether there has been a significant
increase in credit risk.

For trade receivables only, the Company applies the simplified approach permitted by Ind AS 109 Financial Instruments,
which requires expected lifetime losses to be recognised from initial recognition of the receivables.

l. Investment in subsidiaries and joint ventures

Investments in subsidiaries and joint ventures are carried at cost less accumulated impairment losses, if any. Where an
indication of impairment exists, the carrying amount of the investment is assessed and written down immediately to its
recoverable amount. On disposal of these investments, the difference between net disposal proceeds and the carrying
amounts are recognised in the statement of profit and loss.

m. Post-employment and other employee benefits

Provident fund : Retirement benefit in the form of provident fund is a defined contribution scheme. The Company has no
obligation, other than the contribution payable to the provident fund. The Company recognizes contribution payable to the
provident fund scheme as an expense, when an employee renders the related service. The Company has no obligation other
than the contribution payable to the Provided Fund. If the contribution already paid exceeds the contribution due for services
received before the balance sheet date, then excess is recognised as an asset to the extent that the pre-payment will lead to,
for example, a reduction in future payment or a cash refund.

Gratuity : A defined benefit plan is a post-employment benefit plan other than a defined contribution plan. The Company's net
obligation in respect of the gratuity plan (administered through the Life Insurance Corporation of India), which is a defined
benefit plan, is calculated by estimating the ultimate cost to the entity of the benefit that employees have earned in return
for their service in the current and prior periods. This requires an entity to determine how much benefit is attributable to the

current and prior periods and to make estimates (actuarial assumptions) about demographic variables and financial variables
that will affect the cost of the benefit. The cost of providing benefits under the defined benefit plan is determined on the basis
of actuarial valuation using the projected unit credit method. Actuarial gains / losses resulting from re-measurements of the
liability are included in other comprehensive income.

Compensated absences : Compensated absences, which are expected to be utilized within the next 12 months, is treated as
short term employee benefit. The Company measures the expected cost of such absences as the additional amount that it
expects to pay as a result of the unused entitlement that has accumulated at the reporting date.

The Company treats compensated absences expected to be carried forward beyond twelve months, as long-term employee
benefit for measurement purposes. Such long-term compensated absences are provided for based on the actuarial valuation
using the projected unit credit method at the year-end. Actuarial gains / losses are immediately taken to the statement of
profit and loss and are not deferred.

Other short-term benefits : Expense in respect of other short-term benefits is recognized on the basis of amount paid or
payable for the period during which services are rendered by the employees.

n. Earnings per share

Basic earnings per share is calculated by dividing the net profit or loss for the period attributable to equity shareholders (after
deducting attributable taxes) by the weighted average number of equity shares outstanding during the period. The weighted
average number of equity shares outstanding during the period is adjusted for events including a bonus issue.

For the purpose of calculating diluted earnings per share, the net profit or loss for the period attributable to equity shareholders
and the weighted average number of shares outstanding during the period are adjusted for the effects of all dilutive potential
equity shares.

o. Income taxes

Income tax expense recognized in statement of profit and loss comprises current tax and deferred tax except the ones
recognized in other comprehensive income or directly in equity.

Current tax is determined as the tax payable in respect of taxable income for the year and is computed in accordance with the
applicable tax regulations. Current income tax relating to items recognized outside profit or loss is recognized outside profit
or loss (either in other comprehensive income or in equity). The Company offsets current tax assets and current tax liabilities,
where it has a legally enforceable right to set off the recognised amounts and where it intends either to settle on a net basis,
or to realise the asset and liability simultaneously.

Deferred tax is recognized in respect of temporary differences between carrying amount of assets and liabilities for financial
reporting purposes and corresponding amount used for taxation purposes. Deferred tax assets on unrealised tax loss are
recognized to the extent that it is probable that the underlying tax loss will be utilised against future taxable income. This
is assessed based on the Company's forecast of future operating results, adjusted for significant non-taxable income and
expenses and specific limits on the use of any unused tax loss. Unrecognized deferred tax assets are re-assessed at each
reporting date and are recognized to the extent that it has become probable that future taxable profits will allow the deferred
tax asset to be recovered.

Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the year when the asset is realised
or the liability is settled, based on tax rates (and tax laws) that have been enacted or substantively enacted at the reporting
date. Deferred tax relating to items recognized outside statement of profit and loss is recognized outside statement of profit
or loss (either in other comprehensive income or in equity).

p. Government grants

Grants from the government are recognised at their fair value where there is reasonable assurance that the grant will be
received and the group will comply with all the conditions.

Government grants related to the income are deferred and recognised in statement of profit and loss over the period necessary
to match them with the cost that are intended to compensate and presented within other income.

Government grants related to property plant and equipment are included in the non-current liabilities as deferred income and
are credited to profit and loss on a straight-line basis over the expected life of the related assets and presented within other
income.

When the grant relates to an expense item, it is recognised as income on a systematic basis over the periods that the related
costs, for which it is intended to compensate, are expensed. When the grant relates to an asset, it is initially recognised as
deferred income at fair value and subsequently are recognised in standalone statement of profit and loss as other income on
a systematic basis over the expected useful life of the related asset.

q. Segment reporting

Operating segments are reported in a manner consistent with the internal reporting provided to the chief operating decision
maker.

Identification of segments : In accordance with Ind AS 108 - Operating Segment, the operating segments used to present
segment information are identified on the basis of information reviewed by the Company's management to allocate resources to
the segments and assess their performance. An operating segment is a component of the Company that engages in business
activities from which it earns revenues and incurs expenses, including revenues and expenses that relate to transactions with
any of the Company's other components. Results of the operating segments are reviewed regularly by the Board of Director
(Managing Director and Chief Financial officer) which has been identified as the chief operating decision maker (CODM), to
make decisions about resources to be allocated to the segment and assess its performance and for which discrete financial
information is available.

Allocation of common costs : Common allocable costs are allocated to each segment accordingly to the relative contribution
of each segment to the total common costs.

Unallocated items : Unallocated items include general corporate income and expense items which are not allocated to any
business segment.

Segment accounting policies : The Company prepares its segment information in conformity with the accounting policies
adopted for preparing and presenting the financial statements of the Group as a whole. In accordance with Ind AS 108,
Operating Segments, the management has disclosed the segment information in the consolidated financial statements of the
Group.

r. Cash and cash equivalents

Cash and cash equivalent in the balance sheet comprise cash at banks and on hand and short-term deposits with an original
maturity of three months or less, which are subject to an insignificant risk of changes in value.